Влияние ингибиторов фосфодиэстеразы 5 типа на сперматогенез

Автор: Ефремов Е.А., Дорофеев С.Д., Калинченко С.Ю., Куликов А.О.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Организация урологической помощи

Статья в выпуске: 3, 2012 года.

Бесплатный доступ

Ингибиторы фосфодиэстераза 5 типа, фертильность

Короткий адрес: https://sciup.org/142188320

IDR: 142188320

Список литературы Влияние ингибиторов фосфодиэстеразы 5 типа на сперматогенез

Fouad, RK, Swerdloff RS, Pryor J.L. Male reproductive dysfunction 2007. New York: informa. P. 365-384
Кулаков В.И., Леонов Б.В., Кузьмичёва Л.Н., Лечение женского и мужского бесплодия. Москва. 2005. Медицинское информационное агентство. 592 c.
Коновалов О.Е. Бесплодие как медико-демографическая проблема: Автореф. дис..канд. мед.наук. М., 1990. 25 с.
Кулаков В.И., Овсянникова Т.В. Проблемы и перспективы лечения бесплодия в браке.//Акушерство и гинекология. 1997. №5. С. 5-8.
Коновалов О.Е. Современные тенденции распространенности бесплодных браков в зарубежных странах.//Здравоохранение Российской Федерации, 1986. № 7. С. 23-25.
Irvine S, Cawood E,Richardson D, MacDonald E, Aitken J. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years.//BMJ. 1996. Vol.312, № 7029. P. 467-471.
McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction.//Int J Impot Res. 2000. Vol. 12. P. 6-10.
Лопаткин Н.А. Руководство по урологии в 3 томах//Москва.1998. Медицина. 1280 c.
Montorsi F, Salonia A, Deho F, Cestari A, Guazzoni G, Rigatti P, Stief C. Pharmacological management of erectile dysfunction.//BJU Int. 2003. Vol. 91, №5. P. 446-454.
Ковалев В.А. Диагностика и лечение эректильной дисфункции: Автореф. дис.. д-ра мед.наук. М., 2001. 37 с.
Morgentaler A. Male impotence//Lancet, 1999. Vol.354, № 9191. P. 1713-1718.
McVary KT, Carrier S, Wessells H. Smoking and erectile dysfunction: evidence based analysis//J Urol. 2001. Vol.166, № 5. P. 1624-1632.
Fisher WA, Rosen RC, Eardley I, Niederberger C, Nadel A, Kaufman J, Sand MJ The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction.//Sex Med. 2004. Vol.1, № 2. P. 150-160.
Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition//Int J Impot Res. 2004. Vol.16, № 1. P. 11-14.
Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: relating structure and function//Prog Nucleic Acid Res Mol Biol. 2001. Vol. 65. P. 1-52.
Meuleman E, Cuzin B, Opsomer RJ, Hartmann U, Bailey MJ, Maytom MC, Smith MD, Osterloh IH. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction.//BJU Int. 2001. Vol.87, № 1. P. 75-81.
D'Andrea MR, Qiu Y, Haynes-Johnson D, Bhattacharjee S, Kraft P, Lundeen SJ. Expression of PDE11A in normal and malignant human tissues.//Histochem Cytochem. 2005. Vol. 53, № 7. P. 895-903.
Fraser LR, Adeoya-Osiguwa S, Baxendale RW, Mededovic S, Osiguwa OO. First messenger regulation of mammalian sperm function via adenylyl cyclase/cAMP.//J Reprod Dev. 2005. Vol.51, № 1. P. 37-46.
Wayman C, Philips S, Lunny C, Webb T, Fawcett L, Baxendale RW, Burgess G. Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology.//Int J Impot Res. 2005. Vol.17, № 3. P. 216223.
Sinclair ML, Wang XY, Mattia M, Conti M, Buck J, Wolgemuth DJ, Levin LR. Specific expression of soluble adenylyl cyclase in male germ cells.//Mol Reprod Dev. 2000. Vol.56, № 1. P. 6-11.
Nantel F, Monaco L, Foulkes NS, Masquilier D, LeMeur M, Henriksen K, Dierich A, Parvinen M, Sassone-Corsi P. Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice.//Nature. 1996. Vol.380, № 6570. P. 159-162.
Baxendale RW, Fraser LR. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation//Mol Reprod Dev. 2005. Vol.71, № 4. P. 495-508.
Fisch JD, Behr B, Conti M. Enhancement of motility and acrosome reaction in human spermatozoa: differential activation by type-specific phosphodiesterase inhibitors//Hum Reprod. 1998. Vol.13, № 5. P. 1248-1254.
Lewis SE, Donnelly ET, Sterling ES, Kennedy MS, Thompson W, Chakravarthy U. Nitric oxide synthase and nitrite production in human spermatozoa: evidence that endogenous nitric oxide is beneficial to sperm motility.//Mol Hum Reprod. 1996. Vol. 2, № 11. P. 873-878.
de Lamirande E, Leclerc P, Gagnon C. Capacitation as a regulatory event that primes spermatozoa for the acrosome reaction and fertilization//Mol Hum Reprod. 1997. Vol.3, № 3. P. 175-194.
Pomara G, Morelli G, Canale D, Turchi P, Caglieresi C, Moschini C, Liguori G, Selli C, Macchia E, Martino E, Francesca F. Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men.//Fertil Steril. 2007. Vol.88, № 4. P. 860-865.
Cialis® (Tadalafil) label insert. Australia. 2011
Sausen PJ, Reams RY, Morford LL, Dietsch GN. Tadalafil has no effect on testes in rodents.//Int J Impot Res. 2002. Vol.14, № 4. P. 82.
Sikka SC, Hellstrom WJ. The application of pentoxifylline in the stimulation of sperm motion in men undergoing electroejaculation//J Androl. 1991. Vol.12, № 3. P. 165-170.
Burger M, Sikka SC, Bivalacqua TJ, Lamb DJ, Hellstrom WJ. The effect of sildenafil on human sperm motion and function from normal and infertile men.//Int J Impot Res. 2000. Vol.12, № 4. P. 229-234.
Mostafa T. In vitro sildenafil citrate use as a sperm motility stimulant//Fertil Steril. 2007. Vol.88, № 4. P. 994-996.
Lefievre L, De Lamirande E, Gagnon C. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction//J Androl. 2000. Vol.21, № 6. P. 929-937.
Cuadra DL, Chan PJ, Patton WC, Stewart SC, King A. Type 5 phosphodiesterase regulation of human sperm motility.//Am J Obstet Gynecol. 2000. Vol.182, № 5. P. 1013-1015.
Aversa A, Mazzilli F, Rossi T, Delfino M, Isidori AM, Fabbri A. Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males.//Hum Reprod. 2000. Vol.15, № 1. P. 131-134.
Purvis K, Muirhead GJ, Harness JA. The effects of sildenafil on human sperm function in healthy volunteers//Br J Clin Pharmacol. 2002. Vol.53, № 1. P. 53-60.
du Plessis S.S, de Jongh PS, Franken DR. Effect of acute in vivo sildenafil citrate and in vitro 8-bromo-cGMP treatments on semen parameters and sperm function//Fertil Steril. 2004. Vol.81, № 4. P. 1026-1033.
Jannini EA, Lombardo F, Salacone P, Gandini L, Lenzi A. Treatment of sexual dysfunctions secondary to male infertility with sildenafil citrate.//Fertil Steril. 2004. Vol.81, № 3. P. 705-707.
Lenzi A, Lombardo F, Salacone P, Gandini L, Jannini EA. Stress, sexual dysfunctions, and male infertility.//J Endocrinol Invest. 2003. Vol.26, № 3. P. 72-76.
Yamamoto Y, Sofikitis N, Mio Y, Miyagawa I. Influence of sexual stimulation on sperm parameters in semen samples collected via masturbation from normozoospermic men or cryptozoospermic men participating in an assisted reproduction programme.//Andrologia. 2000. Vol.32, № 3. P. 131-138.
Sofikitis NV, Miyagawa I. Endocrinological, biophysical, and biochemical parameters of semen collected via masturbation versus sexual intercourse//J Androl. 1993. Vol.14, № 5. P. 366-373.
Sofikitis N, Takenaka M, Kanakas N, Papadopoulos H, Yamamoto Y, Drakakis P, Miyagawa I. Effects of cotinine on sperm motility, membrane function, and fertilizing capacity in vitro.//Urol Res. 2000. Vol.28, № 6. P. 370-375.
Sofikitis N, Miyagawa I, Secretory dysfunction of the male accessory genital glands due to prostatic infections and fertility: a selected review of literature.//Jpn J Fertil Steril. 1991. Vol.36. P. 690-699.
Kanakas N, Sofikitis N, Kawamura H, Mantzavinos TJ. Effects of Hormones on spermatogenesis in men histological diagnosis of spermatogenic arrest at the primary spermatocytes (PS) stage.//VIIth International Congress of Andrology Androl. 2001. Vol.22. P. 192-204.
Ali ST, Rakkah NI. Neurophysiological role of sildenafil citrate (Viagra) on seminal parameters in diabetic males with and without neuropathy//Pak J Pharm Sci. 2007. Vol.20, № 1. P. 36-42.
Hellstrom WJ, Overstreet JW, Yu A, Saikali K, Shen W, Beasley CM, Watkins VS. Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.//J Urol. 2003. Vol.170, № 3. P. 887-891.
Bauer RJ, Rohde G. A single dose of Vardenafil had no acute effect on sperm motility in healthy males//27th annual meetingof the American Society of Andrology. 2002. Seattle.Washington, USA.
Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.//Int J Impot Res. 1996. Vol.8, № 2. P. 47-52.
Saenz de Tejada I, Angulo J, Cuevas P, Fernandez A, Moncada I, Allona A, Lledo E, Korschen HG, Niewohner U, Haning H, Pages E, Bischoff E. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.//Int J Impot Res. 2001. Vol.13, № 5. P. 282-290.
Saenz de Tejada I, Frutos JA, Gaudo M, Florio V. Comparative selectivity: profiles of tadalafil, sildenafil and vardenafil using an in vitro phosphodiesterase activity assay.//Int J Impot Res. 2002. Vol.14, № 4. P. 20-32.
Baxendale RW, Smith EJ, Stanley M. Selectivity ofsildenafil citrate and other phosphodiesterases type 5 inhibitors against phosphodiesterases types 7-11.//J Clin Pharmacol. 2001. Vol.41. P. 1015.
Wallis RM, Corbin JD, Francis SH, Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.//Am J Cardiol. 1999. Vol.83, № 5A. P. 3-12.
Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors//Int J Clin Pract. 2002. Vol.56, № 6. P. 453-459.

Еще

Статья